Certification of gene mutations associated with congenital lipoid adrenal hyperplasia

摘要

Length (2) is; hStAR pseudogene DNA hStARcDNA that has been described 1 (1), in Table 7 or Table 6, or hStAR genomic DNA,: (57) a DNA or RNA molecule that has been isolated [summary] single There the second sequence is a subsequence of the first sequence of at least 10 nucleotides; SEQ third is substituted with nucleotides nucleotides differ in at least one of the sequence of the first or second (3) the; (4) The first (5) or said; SEQ fourth one nucleotide is inserted at least to the sequence of the first or second said one nucleotide is or is deleted at least from the sequence of the first or second the comprises a fifth sequence complementary to any of the sequences of the second or third, where (1) the molecule, the sequence (1) - U T is in any one of (5) may be a RNA molecule which has been replaced, the sequence of the third (2) the is at least 95% identical to the sequence of the first or second said, the second sequence (3) the the is not present in the mouse StARcDNA, fourth array (4) the can, with the proviso that it does not contain a deletion more nucleotides 200 and more nucleotides inserted 20.